Back

Development of a risk stratification model for permanent pacemaker implantation after Transcatheter Aortic Valve Replacement (TAVR)

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Lifestyle modification: atrial fibrillation and risk stratification Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tong Liu

2nd Hospital of Tianjin Medical University, Tianjin (China)

5 More presentations in this session

Presentation thumbnail
Real-world implantable cardioverter-defibrillator outcomes in a north-african tertiary centre: baseline profile, arrhythmic therapies, device-related events and early outcomes
Doctor N. Dahimene (Tipaza, DZ)
Abstract Slides
Presentation thumbnail
Optimal near-field unipolar voltage thresholds using a lattice-tip mapping catheter corresponding to bipolar low-voltage areas in atrial fibrillation ablation
Doctor T. Ozaki (Osaka, JP)
Abstract Slides
Presentation thumbnail
Omega-3-fatty-acid eicosapentaenoic acid (EPA) associates with reduced QTc in patients with atrial fibrillation
Mrs M. Allemann (Zurich, CH)
Abstract Slides
Presentation thumbnail
Lifestyle profile and adverse outcomes in atrial fibrillation: a modified life’s simple 7 (LS7) analysis from two prospective observational registries from europe and east Asia
Doctor E. Tartaglia (Modena, IT)
Abstract Slides
Presentation thumbnail
Changes in cardiorespiratory fitness in non-permanent atrial fibrillation and quality of life
Mr A. Sellevold (Trondheim, NO)
Abstract Slides

Access the full session

Session thumbnail
Lifestyle modification: atrial fibrillation and risk stratification

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve implantation: a meta-analysis
31 August 2020
thumbnail
Congress Presentation
Development of a risk stratification score based on social predictors in patients undergoing implantable cardioverter defibrillator
29 June 2021
thumbnail
Congress Presentation
Comparing machine learning models with established risk scores in predicting bleeding and ischaemic stroke in patients with atrial fibrillation undergoing transcatheter aortic valve implantation
31 August 2025
thumbnail
Congress Presentation
Evaluation of new-onset atrial fibrillation using continuous patch monitor in patients undergoing transcatheter aortic valve replacement
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources